Dr. Mark J. Holterman is currently one of the most popular figures in the health sector. He studied Bachelor of Arts, Biology at Yale University and later joined the University of Virginia for his Ph.D. and MD in Medicine and Immunology. He is currently a professor at the University of Illinois College of Medicine teaching surgery and pediatrics. He is also a pediatric surgeon at Children’s Hospital of Illinois and Advocate Christ Children’s Hospital.
Dr. Mark Holterman is a member of several professional groups including; American Diabetes Association, American Association of Clinical Anatomy, Association of Academic Surgeons, Federation of Clinical Immunology Societies and Pacific Association of Pediatric Surgeons. He has also received several awards and recognition such as the Innovative Research Award, Merit Scholar and Top Doctors in the Nation.
Alliance for the Advancement of Cellular Therapies is a non-profit organization that works towards promoting ethical advanced and prompt regenerative cell therapies. Among the co-founders of AACT is Dr. Mark J. Holterman (https://health.usnews.com/doctors/mark-holterman-3618). The organization banks on donors and sponsors to accomplish its aim of making cell therapies a standard healthcare alternative for patients.
The donations received are used to train more professionals as well as widen the understanding of cell therapies and its benefits. Donors can give their contributions using major cards and cheque. Contributions can be made in honor of special occasions such as the anniversary of loved ones.
As the co-founder of the Alliance for the Advancement of Cellular Therapies, Dr. Holterman is involved in the field of regenerative medicine. AACT is focused on growing medical knowledge and access to cellular therapy. The cell therapies include regeneration of tissues and treatment of complicated conditions using a transplanted human cell.
Adult stem cells are preferred in regenerative medicine and cellular therapies because they are abundant and its medicinal application is cost effective. In a situation where there is an injury, stem cells trigger tissues around the wound to start the healing process (Doctor.WebMD). The stem cells then move to the inflamed parts to aid the process. This is when the physicians harvest the cells and reintroduce them artificially to parts that need them more.